Chile: Civil Society, Members Of Congress Urge Issuance Of Compulsory Licences 21/03/2017 by Intellectual Property Watch 1 Comment Representatives of Chilean civil society and Congress this week presented the Chilean health minister with a proposal urging the government to take advantage of international trade law and a newly passed congressional resolution to issue compulsory licences on high-priced drugs for hepatitis C and prostate cancer.
Intellectual Property: A Very Short Introduction, New From Oxford University Press 20/03/2017 by Kim Treanor for Intellectual Property Watch Leave a Comment In Intellectual Property: A Very Short Introduction, by Siva Vaidhyanathan, readers are introduced to the basics of intellectual property, framed in a way that illustrates how intellectual property both shapes and is shaped by larger economic, political and social contexts.
Do US Patent Incentives Need To Change To Get The ‘Cancer Moonshot’ Off The Ground? 16/03/2017 by Kim Treanor for Intellectual Property Watch 1 Comment In December, the United States Congress passed a bill with a monumental goal: engaging the private sector to work with each other, and with the government, to develop new treatments for cancer. The mechanics of cancer research, however, may require fundamental changes to our patent system if the initiative is to be successful. Intellectual Property Watch recently sat down with Jacob Sherkow, associate professor of law and affiliated faculty at the Innovation Center for Law and Technology at New York University Law School, to discuss challenges to overcome to get the Moonshot off the ground.
Workshop: How To Tackle The High Cost Of Prescription Drugs In The US 09/03/2017 by Kim Treanor for Intellectual Property Watch 1 Comment A recent workshop held on the doorstep of policymakers in the United States drew speakers from academic and activist circles to examine the mechanisms in US law which could help lead to lower prescription drug prices.
USTR Issues 2017 Trade Policy Review, Listing IPR Priorities 01/03/2017 by Kim Treanor for Intellectual Property Watch and William New 2 Comments The Office of the United States Trade Representative today released its 2017 trade policy agenda. The report includes numerous references to intellectual property rights, mainly focused on enforcement, plans for multilateral discussions on IPR and trade, and promises of an aggressive stance on geographical indications. But overall it is short on overall details about what’s to come with the new administration.
A Look At Latest Figures On R&D For Neglected Diseases 01/03/2017 by Kim Treanor for Intellectual Property Watch 2 Comments Financing for research and development into so-called neglected diseases – those predominantly affecting lower-income populations – rose recently mainly due to the Ebola outbreak, and private sector contributions represent a bigger share, according to the latest available data from a Gates Foundation-supported database.
South Centre Paper Sees IP In Free Trade Agreements Interfering With UN SDGs 27/02/2017 by Kim Treanor for Intellectual Property Watch 1 Comment A new paper from the intergovernmental South Centre argues that intellectual property provisions in recent free trade agreements would impair countries trying to fulfil the United Nations Sustainable Development Goals. Image Credits: South Centre
European Commission Public Consultation On Plan To Fight Antimicrobial Resistance 21/02/2017 by Intellectual Property Watch 2 Comments The European Commission has launched a call for comments on its proposed plan to help EU members fight antimicrobial resistance.
BIO Investor Conference: New Technologies, Old Pricing Systems, And Insurance Payers In The US 20/02/2017 by Kim Treanor for Intellectual Property Watch 1 Comment NEW YORK — At a recent biotechnology investors event in the United States, the prospect of repeal or redesign of the Affordable Care Act, the president’s recent remarks on the prospect of Medicare negotiating prices directly with pharmaceutical corporations, and the public debate surrounding high priced medicines, meant few panels were immune from questions of affordability, access and payment.
Fashion Law – New US/EU Legislation And Retailers: Customer Data And Trademarks 14/02/2017 by Kim Treanor for Intellectual Property Watch Leave a Comment NEW YORK — The fourth annual Fashion Law Seminar, organised by the Federal Bar Association Intellectual Property Section, presented on new legislation in the United States and European Union, and its potential impact on domestic and transnational retailers.